-
1
-
-
0038385271
-
Hepatotoxicity associated with non-steroidal anti-inflammatory drugs
-
Teoh NC, Farrell GC. Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clin Liver Dis 2003; 7: 401-413.
-
(2003)
Clin Liver Dis
, vol.7
, pp. 401-413
-
-
Teoh, N.C.1
Farrell, G.C.2
-
2
-
-
4344661128
-
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
-
Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004; 364: 665-674.
-
(2004)
Lancet
, vol.364
, pp. 665-674
-
-
Schnitzer, T.J.1
Burmester, G.R.2
Mysler, E.3
Hochberg, M.C.4
Doherty, M.5
Ehrsam, E.6
-
3
-
-
78751500917
-
-
Drug safety update: Lumiracoxib hepatotoxicity. Available from Accessed December 2,
-
Drug safety update: Lumiracoxib hepatotoxicity. Available from Accessed December 2, 2010.
-
(2010)
-
-
-
5
-
-
0022355426
-
Halothane hepatitis. Detection of a constitutional susceptibility factor
-
Farrell GC, Prendergast D, Murray M. Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med 1985; 313: 1300-1314.
-
(1985)
N Engl J Med
, vol.313
, pp. 1300-1314
-
-
Farrell, G.C.1
Prendergast, D.2
Murray, M.3
-
7
-
-
77955082302
-
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
-
Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, et al. A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nature 2010; 42: 711-714.
-
(2010)
Nature
, vol.42
, pp. 711-714
-
-
Singer, J.B.1
Lewitzky, S.2
Leroy, E.3
Yang, F.4
Zhao, X.5
Klickstein, L.6
-
8
-
-
77952718055
-
Risk factors for idiosyncratic drug-induced liver injury
-
Chalasani N, Björnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010; 138: 2246-2259.
-
(2010)
Gastroenterology
, vol.138
, pp. 2246-2259
-
-
Chalasani, N.1
Björnsson, E.2
-
9
-
-
0028274260
-
Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis
-
Berson A, Fréneaux E, Larrey D, Lepage V, Douay C, Mallet C, et al. Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J Hepatol 1994; 20: 336-342.
-
(1994)
J Hepatol
, vol.20
, pp. 336-342
-
-
Berson, A.1
Fréneaux, E.2
Larrey, D.3
Lepage, V.4
Douay, C.5
Mallet, C.6
-
10
-
-
0003963036
-
Schiff's Diseases of the Liver
-
10. Philadelphia: Lippincott Williams & Wilkins, Drug induced liver disease. In: Schiff ER, Sorrell MF, Maddrey WC
-
Chitturi S, Farrell GC. Drug induced liver disease. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, ed. 10. Philadelphia: Lippincott Williams & Wilkins; 2007.
-
(2007)
-
-
Chitturi, S.1
Farrell, G.C.2
-
12
-
-
33646024613
-
Hy's law: predicting serious hepatotoxicity
-
Temple R. Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 2006; 15: 241-243.
-
(2006)
Pharmacoepidemiol Drug Saf
, vol.15
, pp. 241-243
-
-
Temple, R.1
-
13
-
-
40949127393
-
How to interpret a genome-wide association study
-
Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008; 299: 1335-1344.
-
(2008)
JAMA
, vol.299
, pp. 1335-1344
-
-
Pearson, T.A.1
Manolio, T.A.2
-
14
-
-
38949104743
-
Idiosyncratic drug reactions: past, present, and future
-
Uetrecht J. Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol 2008; 21: 84-92.
-
(2008)
Chem Res Toxicol
, vol.21
, pp. 84-92
-
-
Uetrecht, J.1
-
15
-
-
61849090255
-
Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts
-
Kang P, Dalvie D, Smith E, Renner M. Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts. Chem Res Toxicol 2009; 22: 106-117.
-
(2009)
Chem Res Toxicol
, vol.22
, pp. 106-117
-
-
Kang, P.1
Dalvie, D.2
Smith, E.3
Renner, M.4
-
16
-
-
2342541211
-
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity
-
Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, et al. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. HEPATOLOGY 2004; 39: 1430-1440.
-
(2004)
HEPATOLOGY
, vol.39
, pp. 1430-1440
-
-
Aithal, G.P.1
Ramsay, L.2
Daly, A.K.3
Sonchit, N.4
Leathart, J.B.5
Alexander, G.6
-
17
-
-
2542627509
-
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
-
Andrade RJ, Lucena MI, Alonso A, García-Cortes M, García-Ruiz E, Benitez R, et al. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. HEPATOLOGY 2004; 39: 1603-1612.
-
(2004)
HEPATOLOGY
, vol.39
, pp. 1603-1612
-
-
Andrade, R.J.1
Lucena, M.I.2
Alonso, A.3
García-Cortes, M.4
García-Ruiz, E.5
Benitez, R.6
-
18
-
-
78049469917
-
Human leucocyte antigen class II genotype in susceptibility and resistance to coamoxiclav-induced liver injury
-
Donaldson PT, Daly AK, Henderson J, Graham J, Pirmohamed M, Bernal W, et al. Human leucocyte antigen class II genotype in susceptibility and resistance to coamoxiclav-induced liver injury. J Hepatol 2010; 53: 1049-1053.
-
(2010)
J Hepatol
, vol.53
, pp. 1049-1053
-
-
Donaldson, P.T.1
Daly, A.K.2
Henderson, J.3
Graham, J.4
Pirmohamed, M.5
Bernal, W.6
-
19
-
-
0017158302
-
Association of HLA-A3 and HLA- B14 antigens with idiopathic haemochromatosis
-
Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA- B14 antigens with idiopathic haemochromatosis. Gut 1976; 17: 332-334.
-
(1976)
Gut
, vol.17
, pp. 332-334
-
-
Simon, M.1
Bourel, M.2
Fauchet, R.3
Genetet, B.4
-
21
-
-
77952602004
-
Prediction of severe adverse drug reactions using pharmacogenetic biomarkers
-
Tohkin M, Ishiguro A, Kaniwa N, Saito Y, Kurose K, Hasegawa R. Prediction of severe adverse drug reactions using pharmacogenetic biomarkers. Drug Metab Pharmacokinet 2010; 25: 122-133.
-
(2010)
Drug Metab Pharmacokinet
, vol.25
, pp. 122-133
-
-
Tohkin, M.1
Ishiguro, A.2
Kaniwa, N.3
Saito, Y.4
Kurose, K.5
Hasegawa, R.6
|